PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding

This study has been terminated.
(Illogistical results found in interim evaluation.)
Sponsor:
Information provided by:
Orion Corporation, Orion Pharma
ClinicalTrials.gov Identifier:
NCT00562198
First received: November 19, 2007
Last updated: June 12, 2008
Last verified: June 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)